Elmind Capital as of March 31, 2026
Portfolio Holdings for Elmind Capital
Elmind Capital holds 34 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cogent Biosciences (COGT) | 12.8 | $45M | 1.2M | 38.49 | |
| Syndax Pharmaceuticals (SNDX) | 12.3 | $43M | 1.9M | 23.36 | |
| Celldex Therapeutics Com New (CLDX) | 7.8 | $27M | 865k | 31.72 | |
| Cytomx Therapeutics (CTMX) | 6.1 | $21M | 4.6M | 4.70 | |
| Kalvista Pharmaceuticals (KALV) | 5.8 | $21M | 1.0M | 20.13 | |
| Cg Oncology (CGON) | 5.6 | $20M | 292k | 67.68 | |
| Vera Therapeutics Cl A (VERA) | 5.5 | $19M | 483k | 40.23 | |
| Vaxcyte (PCVX) | 5.2 | $18M | 317k | 58.11 | |
| Pharvaris N V (PHVS) | 3.8 | $13M | 476k | 28.25 | |
| Tyra Biosciences (TYRA) | 3.8 | $13M | 350k | 38.30 | |
| Beam Therapeutics (BEAM) | 3.2 | $11M | 476k | 23.83 | |
| Miragen Therapeutics (VRDN) | 3.0 | $11M | 535k | 19.56 | |
| BioCryst Pharmaceuticals (BCRX) | 2.7 | $9.5M | 1.0M | 9.52 | |
| United Therapeutics Corporation (UTHR) | 2.5 | $8.9M | 15k | 592.98 | |
| Cullinan Oncology (CGEM) | 2.1 | $7.5M | 530k | 14.21 | |
| Nurix Therapeutics (NRIX) | 2.0 | $7.1M | 460k | 15.50 | |
| Mbx Biosciences (MBX) | 1.8 | $6.3M | 211k | 29.85 | |
| Krystal Biotech (KRYS) | 1.6 | $5.7M | 22k | 258.32 | |
| Dbv Technologies S A Sponsored Ads (DBVT) | 1.6 | $5.5M | 265k | 20.89 | |
| Relay Therapeutics (RLAY) | 1.5 | $5.3M | 537k | 9.95 | |
| Travere Therapeutics (TVTX) | 1.5 | $5.3M | 178k | 29.71 | |
| Protagonist Therapeutics (PTGX) | 1.1 | $4.0M | 38k | 105.40 | |
| Urogen Pharma (URGN) | 1.1 | $4.0M | 220k | 17.98 | |
| Alumis (ALMS) | 0.8 | $2.9M | 130k | 22.03 | |
| BioMarin Pharmaceutical (BMRN) | 0.8 | $2.7M | 47k | 56.49 | |
| Design Therapeutics (DSGN) | 0.6 | $2.2M | 208k | 10.64 | |
| Apellis Pharmaceuticals (APLS) | 0.6 | $2.0M | 50k | 40.23 | |
| Alector (ALEC) | 0.5 | $1.9M | 900k | 2.15 | |
| Immunocore Hldgs Ads (IMCR) | 0.5 | $1.8M | 58k | 30.15 | |
| Amylyx Pharmaceuticals (AMLX) | 0.4 | $1.6M | 112k | 13.90 | |
| Engene Holdings (ENGN) | 0.4 | $1.4M | 210k | 6.81 | |
| Wave Life Sciences SHS (WVE) | 0.4 | $1.3M | 178k | 7.25 | |
| Supernus Pharmaceuticals (SUPN) | 0.3 | $1.0M | 20k | 51.69 | |
| Edgewise Therapeutics (EWTX) | 0.1 | $315k | 10k | 31.50 |
